Several studies have described decreased INSR expression and/or attenuation of the activation states of INSR signaling molecules in affected brain regions in patients with Alzheimer’s [17–19] and Parkinson’s [56–58] diseases. This evidence concerns the gene INSR and Parkinson disease.